GSK expects return to earnings growth in 2016

Country

United Kingdom

GlaxoSmithKline Plc expects to see earnings grow again in 2016 following a reshaping of its business to focus on pharmaceuticals, vaccines and consumer healthcare and reducing its dependence on the off-patent respiratory medicine Advair.